Rating
Buy
Price target
$225
Previous
$200
Upside at publication
+54%

Rosenblatt analyst John McPeake raised the price target on Palantir (NASDAQ: PLTR) to $225.00 (from $200.00) while maintaining a Buy rating.

“Palantir delivered a significant beat to estimates, accelerated the top line yet again, and guided 2Q and 2026 above the Street.

The U.S. commercial business beat Street forecasts after adjusting for a customer that was recategorized to government in the quarter.

The company guided to a full year revenue forecast where the bottom of the range was above our Street high forecasts.

Palantir is helping enterprises and governments use AI to drive real value, and we think it is showing up in the numbers. Adjusted operating income grew 152% in 1Q, and the guidance puts 2026 at 97%.

We think the company’s integration, orchestration, and Ontology are the key to unlocking AI value in the enterprise.

Our checks with customers, former Palantirians, and SI’s, as well as our knowledge of the product, make us doubt that an LLM provider is going to create a functioning replacement of the Palantir stack over the forecastable time horizon.

We are raising our forecasts and target and reiterating our Buy rating on PLTR.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.